Ambey Laboratories IPO is a book-built issue consisting of 68.64 lakh shares. The IPO includes a fresh issue of 65.52 lakh shares and an offer for sale of 3.12 lakh shares.
The subscription window for the IPO of Ambey Laboratories opens on July 3, 2024, and will close on July 5, 2024. The allotment process is expected to be finalized on Monday, July 8, 2024. Ambey Laboratories’ shares will be listed on the NSE SME platform, with a tentative listing date set for Wednesday, July 10, 2024.
The price bands for the IPO of Ambey Laboratories are yet to be announced. Retail investors can apply for a minimum lot size of 2000 shares. However, the minimum amount of investment required by retail investors is currently unspecified.
Fast Track Finsec Pvt Ltd serves as the book-running lead manager for the Ambey Laboratories IPO, while Link Intime India Private Ltd acts as the registrar. Nikunj Stock Brokers is the market maker for this IPO.
Ambey Laboratories operates in the pharmaceutical and healthcare sectors.
Ambey Laboratories IPO Details:
| Company Name | Ambey Laboratories Limited India Limited |
| Sector | Pharmaceutical |
| IPO Type | SME |
| IPO Open date | 03rd July 2024 |
| IPO Close date | 05th July 2024 |
| OFS | |
| Listing Exchanges | NSE |
| Share Holding Pre-issue | |
| DRHP Draft Prospectus | Click to check |
| RHP Draft Prospects | Click to check |
Ambey Laboratories IPO Lot Size:
| Application | Lot Size | Shares | Amount |
| Retail (Min) | 1 | 2000 | 1,36,000 |
| HNI (Min) | 2 | 4000 | 2,72,000 |
Ambey Laboratories IPO Timeline:
| IPO Open Date | 03rd July 2024 |
| IPO Close Date | 05th July 2024 |
| Basis of Allotment | 08th July 2024 |
| Refund Initiation Date | 09th July 2024 |
| Shares Credit to Demat | 09th July 2024 |
| Listing Date | 10th July 2024 |
FAQ
What is Grey Market Premium (GMP)?
The Grey Market Premium (GMP) represents the price at which an Initial Public Offering (IPO) is traded in the unregulated grey market before its official listing. It serves as an indicator of how the IPO might perform on the listing day. Seeing the latest GMP, investors can estimate the listing performance of the IPO.
